International Prospective REgistry on Pre-pectorAl Breast REconstruction

ConditionBreast Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorEuropean Breast Cancer Research Association of Surgical Trialists

About this trial

This is an international multicenter prospective cohort study aimed at collecting data on breast reconstruction techniques with pre-pectoral implants after mastectomy for breast cancer. The aim of the study is to collect data on the surgical, aesthetic and oncological results, as well as on the quality of life of the patients who will undergo breast reconstruction with a pre-pectoral approach.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Female patients older than 18 years old

Signed informed consent form

Patients undergoing mono or bilateral therapeutic mastectomy

Patients undergoing pre-pectoral implant-based breast reconstruction with implant or expander with or without mesh

Disqualifiers

Male patients

Patients not suitable for surgical treatment

Patients undergoing subpectoral reconstruction

Patients undergoing breast reconstruction with autologous tissue.

Trial population

All patients who are candidates for implant-based reconstruction should be informed about the possible participation to this clinical study. The inclusion and exclusion criteria are verified by the investigator and an informed consent is obtained from the patient. The therapeutic pattern should be followed according to institutional and national standards. Since this is a non-interventional trial, the study sites do not deviate from their own study protocol at any timepoint.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • pre-pectoral breast reconstruction

    Procedure/Surgery

    to prospectively evaluate the utilization of the pre-pectoral approach, and evaluate oncological and aesthetic outcomes related to each type of surgical technique and the use of postmastectomy radiation therapy

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Number of patients with Implant-loss at three months postoperatively

Rate of implant-loss at three months postoperatively defined as the unplanned removal or loss of the implant as a result of infection or other complication

Time frame
three months postoperatively

Secondary outcomes

1

Number of patients with Infection

Rate of infection defined as minor if oral antibiotic was required, major if surgical revision and/or hospitalisation was necessary;

Time frame
three months postoperatively
2

Number of patients with re-admission and re-operation

Rate of re-admission and re-operation

Time frame
three months postoperatively
3

Evaluation of Quality of life

Patient's satisfaction and quaity of life measured through BREASTQ (Breast Reconstruction Module Questionnaire)

Time frame
0, 6, 12 and 24 months
4

Number of Early onset complication

Early onset complication at 3 month follow up: seroma, hematoma/bleeding, skin flap or T junction necrosis, nipple necrosis, wound dehiscence, implant malposition (i.e. rotation, displacement etc..), red-breast syndrome

Time frame
three months postoperatively

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

European Breast Cancer Research Association of Surgical Trialists

Lead sponsor

IRCCS San Raffaele

Sponsor institution

EUBREAST ETS

Collaborator